Targeting CDK12 Obviates the Malignant Phenotypes of Colorectal Cancer through the Wnt/β-Catenin Signaling Pathway

Researchers investigated whether CDK12 could be a potential therapeutic target for patients with colorectal cancer and clarified its underlying mechanism. They found that CDK12, but not CDK13 was required for CRC survival.